558 related articles for article (PubMed ID: 30635846)
21. Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort study.
Rockwood K; Black SE; Song X; Hogan DB; Gauthier S; MacKnight C; Vandorpe R; Guzman A; Montgomery P; Kertesz A; Bouchard RW; Feldman H
J Neurol Sci; 2006 Jan; 240(1-2):7-14. PubMed ID: 16212979
[TBL] [Abstract][Full Text] [Related]
22. Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders.
Fattakhov N; Torices S; Stangis M; Park M; Toborek M
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578464
[TBL] [Abstract][Full Text] [Related]
23. Vascular cognitive impairment: dementia biology and translational animal models.
Barone FC; Rosenbaum DM; Zhou J; Crystal H
Curr Opin Investig Drugs; 2009 Jul; 10(7):624-37. PubMed ID: 19579168
[TBL] [Abstract][Full Text] [Related]
24. The concept of vascular cognitive impairment.
Erkinjuntti T; Gauthier S
Front Neurol Neurosci; 2009; 24():79-85. PubMed ID: 19182465
[TBL] [Abstract][Full Text] [Related]
25. The auditory oddball paradigm in patients with vascular cognitive impairment: a prolonged latency of the N2 complex.
van Harten B; Laman DM; van Duijn H; Knol DL; Stam CJ; Scheltens P; Weinstein HC
Dement Geriatr Cogn Disord; 2006; 21(5-6):322-7. PubMed ID: 16484811
[TBL] [Abstract][Full Text] [Related]
26. The assessment of cognitive and behavioural disturbances in vascular cognitive impairment (VCI) - recommendations of an expert working group.
Calabrese P; Sitek EJ; Korczyn AD; Dong Y; Manso-Calderón R; Sierra-Beltrán M; Skrzypkowska A; Stefanova E
Neurol Neurochir Pol; 2021; 55(4):333-345. PubMed ID: 34096014
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of age-related HIV neurodegeneration.
Mackiewicz MM; Overk C; Achim CL; Masliah E
J Neurovirol; 2019 Oct; 25(5):622-633. PubMed ID: 30790184
[TBL] [Abstract][Full Text] [Related]
28. Clinico-radiological predictors of vascular cognitive impairment (VCI) in patients with stroke: a prospective observational study.
Chaudhari TS; Verma R; Garg RK; Singh MK; Malhotra HS; Sharma PK
J Neurol Sci; 2014 May; 340(1-2):150-8. PubMed ID: 24680559
[TBL] [Abstract][Full Text] [Related]
29. Vascular dementia.
Erkinjuntti T; Rockwood K
Semin Clin Neuropsychiatry; 2003 Jan; 8(1):37-45. PubMed ID: 12567331
[TBL] [Abstract][Full Text] [Related]
30. Guidelines for Evaluation and Management of Cognitive Disorders in HIV-Positive Individuals.
Underwood J; Winston A
Curr HIV/AIDS Rep; 2016 Oct; 13(5):235-40. PubMed ID: 27353598
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and management of vascular cognitive impairment and dementia.
Erkinjuntti T
J Neural Transm Suppl; 2002; (63):91-109. PubMed ID: 12597611
[TBL] [Abstract][Full Text] [Related]
32. HIV-Associated Neurocognitive Disorders: The First Longitudinal Follow-Up of a cART-Treated Cohort of Older People in Sub-Saharan Africa.
Spooner R; Ranasinghe S; Urasa S; Yoseph M; Koipapi S; Mukaetova-Ladinska EB; Lewis T; Howlett W; Dekker M; Kisoli A; Gray WK; Walker RW; Dotchin CL; Kalaria R; Lwezuala B; Makupa PC; Akinyemi R; Paddick SM
J Acquir Immune Defic Syndr; 2022 Jun; 90(2):214-222. PubMed ID: 35125473
[TBL] [Abstract][Full Text] [Related]
33. Contemporary trends in HIV-associated neurocognitive disorders in Ghana.
Sarfo FS; Kyem G; Asibey SO; Tagge R; Ovbiagele B
Clin Neurol Neurosurg; 2021 Nov; 210():107003. PubMed ID: 34715557
[TBL] [Abstract][Full Text] [Related]
34. Vascular cognitive impairment.
van der Flier WM; Skoog I; Schneider JA; Pantoni L; Mok V; Chen CLH; Scheltens P
Nat Rev Dis Primers; 2018 Feb; 4():18003. PubMed ID: 29446769
[TBL] [Abstract][Full Text] [Related]
35. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
Jellinger KA
Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
[TBL] [Abstract][Full Text] [Related]
36. Preclinical vascular cognitive impairment and Alzheimer disease: neuropsychological test performance 5 years before diagnosis.
Ingles JL; Boulton DC; Fisk JD; Rockwood K
Stroke; 2007 Apr; 38(4):1148-53. PubMed ID: 17322075
[TBL] [Abstract][Full Text] [Related]
37. Vascular cognitive impairment.
Rincon F; Wright CB
Curr Opin Neurol; 2013 Feb; 26(1):29-36. PubMed ID: 23254555
[TBL] [Abstract][Full Text] [Related]
38. Study on epidemiology of cognitive dysfunction after stroke in the population over the age of 45 in Inner Mongolia.
Zhang C; She Y; Lan T; Hu B; Zhang G; He J; Wang Z; Jiang M; Hu R
Int J Neurosci; 2018 Jul; 128(7):654-662. PubMed ID: 29172850
[TBL] [Abstract][Full Text] [Related]
39. Current concepts in vascular cognitive impairment and pharmacotherapeutic implications.
Rojas-Fernandez CH; Moorhouse P
Ann Pharmacother; 2009 Jul; 43(7):1310-23. PubMed ID: 19584390
[TBL] [Abstract][Full Text] [Related]
40. Vascular cognitive impairment: current concepts and clinical developments.
Moorhouse P; Rockwood K
Lancet Neurol; 2008 Mar; 7(3):246-55. PubMed ID: 18275926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
